Ramos MC de A, Folgueira MAAK, Maistro S, et al. Cost effectiveness of the cancer prevention program for carriers of the BRCA1/2 mutation. Rev. saúde pública. 2018;52:94. doi:10.11606/S1518-8787.2018052000643